Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Base de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Am Heart J ; 243: 187-200, 2022 01.
Artículo en Inglés | MEDLINE | ID: mdl-34582775

RESUMEN

BACKGROUND: The ISCHEMIA-CKD (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease) trial found no advantage to an invasive strategy compared to conservative management in reducing all-cause death or myocardial infarction (D/MI). However, the prognostic influence of angiographic coronary artery disease (CAD) burden and ischemia severity remains unknown in this population. We compared the relative impact of CAD extent and severity of myocardial ischemia on D/MI in patients with advanced chronic kidney disease (CKD). METHODS: Participants randomized to invasive management with available data on coronary angiography and stress testing were included. Extent of CAD was defined by the number of major epicardial vessels with ≥50% diameter stenosis by quantitative coronary angiography. Ischemia severity was assessed by site investigators as moderate or severe using trial definitions. The primary endpoint was D/MI. RESULTS: Of the 388 participants, 307 (79.1%) had complete coronary angiography and stress testing data. D/MI occurred in 104/307 participants (33.9%). Extent of CAD was associated with an increased risk of D/MI (P < .001), while ischemia severity was not (P = .249). These relationships persisted following multivariable adjustment. Using 0-vessel disease (VD) as reference, the adjusted hazard ratio (HR) for 1VD was 1.86, 95% confidence interval (CI) 0.94 to 3.68, P = .073; 2VD: HR 2.13, 95% CI 1.10 to 4.12, P = .025; 3VD: HR 4.00, 95% CI 2.06 to 7.76, P < .001. Using moderate ischemia as the reference, the HR for severe ischemia was 0.84, 95% CI 0.54 to 1.30, P = .427. CONCLUSION: Among ISCHEMIA-CKD participants randomized to the invasive strategy, extent of CAD predicted D/MI whereas severity of ischemia did not.


Asunto(s)
Enfermedad de la Arteria Coronaria , Isquemia Miocárdica , Insuficiencia Renal Crónica , Angiografía Coronaria , Enfermedad de la Arteria Coronaria/complicaciones , Enfermedad de la Arteria Coronaria/diagnóstico , Enfermedad de la Arteria Coronaria/epidemiología , Humanos , Isquemia/complicaciones , Isquemia Miocárdica/complicaciones , Isquemia Miocárdica/epidemiología , Insuficiencia Renal Crónica/complicaciones , Insuficiencia Renal Crónica/epidemiología , Factores de Riesgo
2.
J Heart Valve Dis ; 17(3): 348-51, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-18592934

RESUMEN

Although sarcomas are the most frequent primary malignant tumor of the heart, they very rarely involve only the left heart valves. A 72-year-old woman was diagnosed with a severe mitral valve disease and referred for cardiac surgery. Preoperative transthoracic echocardiography revealed a cardiac mass involving the mitral and aortic valves. The aortic valve had an unusual appearance, with a cystic mass protruding to the left ventricular outflow tract. The mitral valve apparatus was also involved, with chordal rupture. Extended resection and dual valve replacement was performed. A histological examination revealed an undifferentiated sarcoma. Postoperatively, neither chemotherapy nor radiotherapy therapy was used. Although most patients may benefit from adjunctive therapy, some respond well in the short term with only surgical resection, despite the poor prognosis of this rare entity.


Asunto(s)
Neoplasias Cardíacas/diagnóstico por imagen , Sarcoma/diagnóstico por imagen , Anciano , Válvula Aórtica/diagnóstico por imagen , Válvula Aórtica/cirugía , Ecocardiografía , Femenino , Neoplasias Cardíacas/cirugía , Humanos , Válvula Mitral/diagnóstico por imagen , Válvula Mitral/cirugía , Sarcoma/cirugía , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA